RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 18 - per page Next page
Order by
The development of a transdermal therapeutic system offers the advantages of constant plasma levels i.e. avoiding of plasma peaks and providing of therapeutic plasma level during the early morning hours More
Innovative chewable tablets iron based More
Cancer immunotherapy using dendritic cells, and iii) Camel recombinant antibodies for FoxP3, Mucl & CEA. More
CILOTAX™ Drug Eluting Stent system is designed to treat coronary artery disease bu opening clogged arteris and restoring blood flow More
Surgery is the only treatment for aortic stenosis. We have shown that antagonists to sphingosine 1-phosphate receptors inhibit the production of proinflammatory molecules and calcification markers underlying this disease, thus finding a potential target More
Our gelatin is well established in the UK hospital martket More
Development of a Cellular and Animal Model for Infantile Haemangioma More
Isoplex 4% w/v Solution for Infusion is well established in the UK market and this product may be available for suitable partners to license for registering and marketing in other territories. More
Novel Biomarkers for Detection of Early Onset Neonatal Sepsis (EONS) and other Complications of Prematurity More
Diagnostic Method and Kit for Determining Kell Blood Group Genotype: Without the Need for Obtaining Blood Samples More
Displaying 1..10 of 18 - per page Next page
Order by

Related Reports

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us